Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction
To access this article, please choose from the options below
The study is supported by an educational grant from the OMAA (Austrian-Hungarian Action Foundation-60—u7-) and the Austrian Society of Cardiology to Dr Nyolczas.
PII: S0002-8703(06)00948-3
doi:10.1016/j.ahj.2006.10.027
© 2007 Mosby, Inc. All rights reserved.
